Valiant Laboratories profitability ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024
Returns
−1.2%−1.2%−0.9%0.1%
−0.8%−0.8%−0.6%0.1%
0.1%0.1%−2.1%−3.3%
5.0%0.0%−1.9%−1.6%
Margins
10.9%2.7%−3.5%−4.6%
0.2%0.2%−5.1%−5.7%
—6.8%−7.4%—
8.0%0.3%−1.1%−0.4%
5.2%−1.4%−1.7%0.2%
5.2%−1.4%−1.7%0.2%
−18.8%−18.8%−84.4%−24.2%
Additional
34.7%525.4%−45.5%141.5%
−1.2%−1.2%−0.9%0.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

VALIANTLAB₹125.82

Valiant Laboratories Limited

· Pharma & Health
₹ CrorePeersALBERTDAVDHALEOSLABSZIMLABMEDICOMEDICAMEQANUHPHRAHCLWANBURYMcap ₹683 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity0.13-0.93-1.20-1.20
Return on Assets0.09-0.59-0.76-0.76
Return on Capital Employed-3.31-2.070.100.10
Return on Invested Capital-1.57-1.930.044.98
Margins
EBITDA Margin-4.62-3.512.6910.87
Operating Margin-5.70-5.080.150.15
Incremental Operating Margin—-7.406.84—
Pretax Margin-0.42-1.130.328.02
Net Income Margin0.18-1.65-1.385.23
Net Income to Common Margin0.18-1.65-1.385.23
FCF Margin-24.16-84.37-18.79-18.79
Additional
Effective Tax Rate141.53-45.52525.4034.73
Sustainable Growth Rate0.13-0.93-1.20-1.20
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.